NORTH CHICAGO, Ill., Jan. 12, 2015 -- The U.S. Food and Drug Administration (FDA) has approved AbbVie's (NYSE: ABBV) DUOPA™ (carbidopa and levodopa) enteral suspension for the treatment of motor ...
Until August, Kern Jackson avoided going out in public. Parkinson’s disease had progressed far enough that the levadopa pills he’d taken since 2008 weren’t as reliable to ease the symptom of his ...
Taking pills numerous times a day is a common part of having advanced Parkinson’s disease. Now, some patients are turning to a treatment that provides medication throughout the day via a portable pump ...
DUOPA is the first and only treatment providing 16 continuous hours of carbidopa and levodopa for motor fluctuations in advanced Parkinson's disease · In a clinical trial, patients treated with DUOPA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results